About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Heart Failure Worsens Muscle Strength in COPD | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04261452

Heart Failure Worsens Muscle Strength in COPD

The combination of heart failure (HF) and chronic obstructive pulmonary disease (COPD) is highly prevalent, but underdiagnosed and poorly recognized. It has been suggested that the decline in function...

Lead sponsor: Mayron Faria de Oliveira•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mayron Faria de Oliveira

Collaborators

Coordination for the Improvement of Higher Education Personnel

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•non-cachectic sedentary patients
•moderate-to-severe COPD according to GOLD classification (FEV1/ FVC \<0.7 and predicted post-bronchodilator FEV1 between 30% and 80%)
•no clinical or echocardiographic evidence of HF for the COPD group
•echocardiographic evidence of HF with reduced left ventricular ejection fraction (\<40%) for the overlap group
•chronic dyspnoea (MRC scale score 2-4)
•NYHA class 2 or 3.

Exclusion Criteria

•long-term O2 therapy
•recent (within a year) rehabilitation program
•osteomuscular limitation
•type I or non-controlled type II diabetes mellitus
•peripheral arterial disease associated with claudication
•Patients with preserved ejection fraction HF

Related studies

Pulmonary Rehabilitation for Rural Patients With COPD

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

Inspiratory Muscle Training After Vertebroplasty in Osteoporotic Fracture Patients

NCT07024095 · Osteoporotic Vertebral Compression Fractures, Restrictive Pulmonary Disorders, and more

Study of Patient With Frequent Exacerbations in Moscow

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease and Asthma in Workers at Navanakorn Industrial Zone, Thailand

NCT07383896 · Asthma, COPD

Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

NCT07112235 · COPD (Chronic Obstructive Pulmonary Disease), Rhinovirus Infection, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 7, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateAug 2014

Last updatedFeb 7, 2020

Condition

COPD CHF Muscle Weakness

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 7, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions